Perk Pharmaceuticals Ltd

Perk Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Perk Pharmaceuticals Ltd

₹ None%
- close price
Company website BSE: 530673
About

Perk Pharmaceuticals Ltd. engages in manufactures and markets specialty pharmaceuticals.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE 1.73 %
  • ROE 1.24 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 1.20% over past five years.
  • Company has a low return on equity of 2.58% over last 3 years.
  • Company has high debtors of 588 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011
1.14 1.42 1.30 1.40 1.32 1.21
1.64 1.14 1.43 1.20 0.81 0.97
Operating Profit -0.50 0.28 -0.13 0.20 0.51 0.24
OPM % -43.86% 19.72% -10.00% 14.29% 38.64% 19.83%
0.00 0.00 0.01 0.00 0.00 0.00
Interest 0.04 0.05 0.02 0.03 0.04 0.03
Depreciation 0.14 0.13 0.16 0.15 0.14 0.14
Profit before tax -0.68 0.10 -0.30 0.02 0.33 0.07
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.68 0.10 -0.30 0.02 0.33 0.07
EPS in Rs
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 1%
3 Years: -2%
TTM: -8%
Compounded Profit Growth
10 Years: %
5 Years: 16%
3 Years: 31%
TTM: -79%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 1%
3 Years: 3%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011
Equity Capital 6.38 6.38 6.38 6.38 6.38 6.38
Reserves -2.61 -0.85 -1.15 -1.13 -0.79 -0.72
0.47 0.35 0.46 0.33 0.27 0.02
1.07 0.99 0.85 0.42 0.85 1.40
Total Liabilities 5.31 6.87 6.54 6.00 6.71 7.08
2.87 4.39 4.17 4.02 3.88 3.82
CWIP 0.08 0.08 0.10 0.10 0.10 0.10
Investments 0.00 0.00 0.00 0.00 0.00 0.00
2.36 2.40 2.27 1.88 2.73 3.16
Total Assets 5.31 6.87 6.54 6.00 6.71 7.08

Cash Flows

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011
0.02 0.15 0.03 -0.08 0.05 0.58
-0.03 -0.01 0.03 0.00 0.00 -0.08
0.01 -0.12 0.11 -0.13 -0.05 -0.25
Net Cash Flow 0.00 0.02 0.17 -0.21 0.00 0.25

Ratios

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011
Debtor Days 105.66 138.80 168.46 224.21 461.78 588.22
Inventory Days 471.46 849.33 385.74 418.85 730.00 556.62
Days Payable 117.86 224.62 153.47 149.59 343.53 766.50
Cash Conversion Cycle 459.25 763.51 400.73 493.48 848.25 378.35
Working Capital Days 361.80 323.87 314.46 362.39 503.26 437.40
ROCE % 2.96% -4.84% 0.89% 6.47% 1.73%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.